Table 1.

Clinical characteristics and risk factors of 19 ESCC samples

No.	ID	Age(y)/sex	TNM stage	Stage	Histology grade	Tumor location	Smoking (Y/N)	Drinking (Y/N)	Family history of cancer	Genomic size of total gain, Mb	Genomic size of total loss, Mb	Net imbalances, Mb (%)
1	33T	72/M	T2N1M0	IIB	Moderate	lower	N	N	N	302.7	181.4	+121.3 (4.0)
2	39T	58/M	T3N2M0	IIIB	Moderate	lower	Y	Y	N	136.1	0	+136.1 (4.5)
3	44T	60/M	T3NXM0	N/A	Moderate	lower	Y	Y	N	668.9	831.6	-162.7(5.4)
4	57T	50/M	T3N2M0	IIIB	Moderate	lower	Y	Y	Y	267.9	108.1	+159.8 (5.3)
5	61T	76/F	T3N3M0	IIIC	Moderate	lower	Y	N	N	119.6	352.4	-232.8 (7.8)
6	74T	47/M	T3N3M0	IIIC	Moderate	lower	Y	Y	N	536	48.3	+487.7 (16.3)
7	79T	40/M	T3N0M0	IIA	Moderate	lower	Y	Y	N	232.7	896.1	-663.4 (22.1)
8	80T	67/M	T3N1M0	IIIA	Moderate	lower	Y	Y	N	830.5	806.4	+24.1 (0.8)
9	97T	46/M	T3N0M0	IIA	Moderate	lower	Y	Y	N	238.4	29.6	+208.8 (7.0)
10	TL0140	44/M	T1N0M0	IB	Moderate	upper	N	N	Y (EC)	525.6	604.6	-79 (2.6)
11	TL0134	48/M	T3N1M0	IIIA	Moderate	lower	Y	Y	Y	454.8	375.7	+79.1 (2.6)
12	TL0129	55/M	T3N0M0	IIB	Moderate	upper	Y	Y	N	549.2	460.9	+88.3 (2.9)
13	TL0128	72/M	T2NXM0	N/A	Well	lower	Y	Y	Y (EC)	1090.6	1298.7	-208.1 (6.9)
14	TL0127	65/M	T3N1M0	IIIA	Moderate	middle	Y	Y	N	911.1	410.9	+500.2 (16.7)
15	TL0124	61/M	T1N0M0	IB	Moderate	lower	N	Y	N	787.2	752.5	+34.7 (1.2)
16	TL0122	60/M	T1N1M0	IIB	Moderate	lower	Y	Y	N/A	756.7	62.3	+694.4 (23.1)
17	TL0123	52/M	T2N0M0	IIB	Moderate	upper	Y	Y	N	1022.2	414.2	+608 (20.3)
18	TL0110	37/M	T3N1M0	IIIA	Moderate	lower	Y	Y	N	801.3	598.7	+202.6 (6.8)
19	TL0105	66/M	T2NXM0	N/A	Moderate	lower	Y	Y	N	394.3	787.4	-393.1 (13.1)

Abbreviations: N/A, not available; TNM, tumor, node, metastasis; Y/N, yes/no